The five human herpesviruses: infection, prevention, and treatment.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000517:prevention & control; D002644:Chickenpox / Q000517:prevention & control; D003586:Cytomegalovirus Infections / Q000517:prevention & control; D005260:Female; D006561:Herpes Simplex / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control; D006562:Herpes Zoster / Q000517:prevention & control; D006566:Herpesviridae Infections / Q000150:complications / Q000517:prevention & control / Q000628:therapy*; D004854:Herpesvirus 4, Human; D006801:Humans; D007116:Immunization, Passive; D007223:Infant; D007231:Infant, Newborn; D007244:Infectious Mononucleosis / Q000517:prevention & control; D008297:Male; D010778:Photochemotherapy; D002583:Uterine Cervical Neoplasms / Q000209:etiology; D014765:Viral Vaccines / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D014765:Viral Vaccines